ALXN
Capital Research Global Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-144,486
| Closed | -$17.3M | – | 462 |
|
|
2017
Q4 | $17.3M | Buy |
144,486
+423
| +0.3% | +$50.6K | 0.01% | 386 |
|
|
2017
Q3 | $20.2M | Buy |
144,063
+1,868
| +1% | +$262K | 0.01% | 381 |
|
|
2017
Q2 | $17.3M | Buy |
142,195
+970
| +0.7% | +$118K | 0.01% | 386 |
|
|
2017
Q1 | $17.1M | Sell |
141,225
-7,149,175
| -98% | -$867M | 0.01% | 387 |
|
|
2016
Q4 | $892M | Sell |
7,290,400
-8,014,731
| -52% | -$981M | 0.29% | 91 |
|
|
2016
Q3 | $1.88B | Sell |
15,305,131
-10,284,191
| -40% | -$1.26B | 0.62% | 43 |
|
|
2016
Q2 | $2.99B | Sell |
25,589,322
-2,012,885
| -7% | -$235M | 1.02% | 22 |
|
|
2016
Q1 | $3.84B | Hold |
27,602,207
| – | – | 1.32% | 12 |
|
|
2015
Q4 | $5.27B | Buy |
27,602,207
+194,323
| +0.7% | +$37.1M | 1.8% | 8 |
|
|
2015
Q3 | $4.29B | Buy |
27,407,884
+1,074,143
| +4% | +$168M | 1.53% | 10 |
|
|
2015
Q2 | $4.76B | Buy |
26,333,741
+1,570,549
| +6% | +$284M | 1.56% | 11 |
|
|
2015
Q1 | $4.29B | Buy |
24,763,192
+473,092
| +2% | +$82M | 1.47% | 10 |
|
|
2014
Q4 | $4.49B | Buy |
24,290,100
+49,800
| +0.2% | +$9.21M | 1.53% | 11 |
|
|
2014
Q3 | $4.02B | Buy |
24,240,300
+10,235
| +0% | +$1.7M | 1.39% | 12 |
|
|
2014
Q2 | $3.79B | Buy |
24,230,065
+745,592
| +3% | +$116M | 1.32% | 13 |
|
|
2014
Q1 | $3.57B | Sell |
23,484,473
-218,639
| -0.9% | -$33.3M | 1.29% | 12 |
|
|
2013
Q4 | $3.15B | Buy |
23,703,112
+1,498,586
| +7% | +$199M | 1.17% | 13 |
|
|
2013
Q3 | $2.58B | Buy |
22,204,526
+776,426
| +4% | +$90.2M | 1.02% | 19 |
|
|
2013
Q2 | $1.98B | Buy |
+21,428,100
| New | +$1.98B | 0.84% | 25 |
|